Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31076

1.

Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.

Morrisroe K, Sudararajan V, Stevens W, Sahhar J, Zochling J, Roddy J, Proudman S, Nikpour M.

Rheumatology (Oxford). 2017 Oct 9. doi: 10.1093/rheumatology/kex362. [Epub ahead of print]

PMID:
29155994
2.

14-3-3z sequesters cytosolic T-bet, up-regulating IL-13 in Tc2 and scleroderma CD8+ lymphocytes.

Cascio S, Medsger TA Jr, Hawse WF, Watkins SC, Milcarek C, Moreland LW, Lafyatis RA, Fuschiotti P.

J Allergy Clin Immunol. 2017 Nov 15. pii: S0091-6749(17)31760-8. doi: 10.1016/j.jaci.2017.10.029. [Epub ahead of print]

PMID:
29155097
3.

Meta-analysis of the association between <i>NLRP1</i> polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases.

Li J, Yan M, Zhang Y, Feng C, Wang H, Wang C, Sun L.

Oncotarget. 2017 Sep 22;8(50):88179-88188. doi: 10.18632/oncotarget.21165. eCollection 2017 Oct 20.

PMID:
29152150
4.

Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-Polymyositis Overlap Syndrome Associated with Anti-Ku Antibody.

Takeshi Y, Mai Y, Kinjo M, Manabu J, Itsuro H.

Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9363-17. [Epub ahead of print]

PMID:
29151520
5.

The relationship between the degree of skin fibrosis by sonoelastography and the degree of pulmonary involvement in scleroderma

Çildağ S, Çildağ MB.

Turk J Med Sci. 2017 Nov 13;47(5):1555-1559. doi: 10.3906/sag-1702-44.

PMID:
29151332
6.

Physical activity in patients with systemic sclerosis.

Liem SIE, Meessen JMTA, Wolterbeek R, Ajmone Marsan N, Ninaber MK, Vliet Vlieland TPM, de Vries-Bouwstra JK.

Rheumatol Int. 2017 Nov 18. doi: 10.1007/s00296-017-3879-y. [Epub ahead of print]

PMID:
29151128
7.

Instruments to assess stigmatization in dermatology.

Dimitrov D, Szepietowski JC.

Postepy Hig Med Dosw (Online). 2017 Nov 3;71(0):901-905. doi: 10.5604/01.3001.0010.5607.

PMID:
29151062
8.

Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Frech TM, Mar D.

Rheum Dis Clin North Am. 2018 Feb;44(1):15-28. doi: 10.1016/j.rdc.2017.09.002. Review.

PMID:
29149923
9.

Post-Irradiation Morphea in Breast Cancer: An Uncommon Differential Diagnosis to Keep in Mind.

Afonso-Afonso FJ, Arevalo MP, Cerecedo FC, De Paz Arias L, Tonder CD.

World J Oncol. 2010 Dec;1(6):250-251. doi: 10.4021/wjon264w. Epub 2011 Jan 1.

PMID:
29147217
10.

Network pharmacological mechanisms of Vernonia anthelmintica (L.) in the treatment of vitiligo: Isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes.

Wang JY, Chen H, Wang YY, Wang XQ, Chen HY, Zhang M, Tang Y, Zhang B.

BMC Syst Biol. 2017 Nov 16;11(1):103. doi: 10.1186/s12918-017-0486-1.

11.

Defining a unified vascular phenotype in systemic sclerosis.

Allanore Y, Distler O, Matucci-Cerinic M, Denton CP.

Arthritis Rheumatol. 2017 Nov 16. doi: 10.1002/art.40377. [Epub ahead of print] Review.

PMID:
29145709
12.

STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis post-transcriptionally and is essential for lung myofibroblast differentiation.

Papaioannou I, Xu S, Denton CP, Abraham DJ, Ponticos M.

Mol Biol Cell. 2017 Nov 15. pii: mbc.E17-06-0342. doi: 10.1091/mbc.E17-06-0342. [Epub ahead of print]

PMID:
29142074
13.

The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Stawski L, Marden G, Trojanowska M.

J Immunol. 2017 Nov 15. pii: ji1601968. doi: 10.4049/jimmunol.1601968. [Epub ahead of print]

PMID:
29141862
14.

A Case Report of Generalised Morphea.

Shah RN, Marquis L, Mehta TK.

Indian J Dermatol Venereol. 1973 Sep-Oct;39(5):199-202. No abstract available.

15.

Estimating autoantibody signatures to detect autoimmune disease patient subsets.

Wu Z, Casciola-Rosen L, Shah AA, Rosen A, Zeger SL.

Biostatistics. 2017 Nov 13. doi: 10.1093/biostatistics/kxx061. [Epub ahead of print]

PMID:
29140482
16.

Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.

Wermuth PJ, Piera-Velazquez S, Jimenez SA.

Rheumatology (Oxford). 2017 Nov 13. doi: 10.1093/rheumatology/kex404. [Epub ahead of print]

PMID:
29140474
17.

Localized Scleroderma, Systemic Sclerosis and Cardiovascular Risk: A Danish Nationwide Cohort Study.

Hesselvig JH, Kofoed K, Wu JJ, Dreyer L, Gislason G, Ahlehoff O.

Acta Derm Venereol. 2017 Nov 14. doi: 10.2340/00015555-2842. [Epub ahead of print]

18.

[Investigation of parameters related to prognosis in diffuse parenchymal lung diseases prognosis in interstitial lung diseases].

Canıvar C, Bingöl Z, Kılıçaslan Z, Çağatay T, Okumuş NG.

Tuberk Toraks. 2017 Sep;65(3):210-219. doi: 10.5578/tt.57501. Turkish.

PMID:
29135399
19.

Factors Associated with Development of Vitiligo in Patients with Halo Nevus.

Zhou H, Wu LC, Chen MK, Liao QM, Mao RX, Han JD.

Chin Med J (Engl). 2017 Nov 20;130(22):2703-2708. doi: 10.4103/0366-6999.218011.

20.

Methoxsalen-induced macular toxicity.

Maitray A, Rishi P.

Indian J Ophthalmol. 2017 Nov;65(11):1243-1245. doi: 10.4103/ijo.IJO_413_17.

Supplemental Content

Loading ...
Support Center